Genzyme Fights Dismissal Of D&O Policy Suit
Genzyme Corp. is challenging the dismissal of its suit against Federal Insurance Co. that called for the insurer to pick up the tab for a securities class action the biotechnology company...To view the full article, register now.
Already a subscriber? Click here to view full article